霍奇金淋巴瘤（霍奇金病）

预约门诊

分期

如果已经确诊霍奇金淋巴瘤，下一步是确定癌症的扩散范围（称为分期）。可能使用影像学检查、血液检测和活检来确定霍奇金淋巴瘤的分期。医护团队使用癌症分期来帮助制定治疗计划。

霍奇金淋巴瘤的分期包括 1 期到 4 期：

  • 淋巴瘤 1 期。 霍奇金淋巴瘤 1 期仅累及一个淋巴结区域。
  • 淋巴瘤 2 期。 霍奇金淋巴瘤 2 期累及隔膜同侧的两个或多个淋巴结区域。
  • 淋巴瘤 3 期。 霍奇金淋巴瘤 3 期累及隔膜两侧的淋巴结区域。
  • 淋巴瘤 4 期。 霍奇金淋巴瘤 4 期累及淋巴结以外的区域。

霍奇金淋巴瘤分期也可能包括字母 A 和 B。字母 A 表示没有出现令人担心的淋巴瘤症状。字母 B 表示出现了某些症状，如严重盗汗、发热或体重下降。

霍奇金淋巴瘤预后

癌症预后能告知您癌症可被治疗或治愈的可能性。您的预后可能取决于：

  • 您的年龄。
  • 整体健康状况。
  • 您所患霍奇金淋巴瘤的类型。
  • 癌症分期。
  • 您的血液检测结果。

对于霍奇金淋巴瘤，医务人员可能会将您的预后分为以下三类之一：

  • 早期低危。 这意味着您的癌症处于 1 期或 2 期，且没有影响预后的风险因素。
  • 早期高危。 这意味着您的癌症处于 1 期或 2 期，但您存在一个或多个风险因素。
  • 晚期。 这意味着您的癌症处于 3 期或 4 期。

影响您预后的风险因素包括您的年龄、淋巴结大小（尤其是胸部淋巴结）、是否有症状，以及受累淋巴结区域的数量。另一个风险因素是红细胞在试管中的沉降速度。这一指标被称为红细胞沉降率。沉降率高于正常水平可能意味着癌症进展更快。

如果您想了解预后情况，请咨询医护团队。医护团队成员可以阐明在评估您的预后时会考虑哪些因素。

申请预约
诊断与治疗生存率
Sept. 24, 2025

Living with 霍奇金淋巴瘤（霍奇金病）?

Connect with others like you for support and answers to your questions in the Blood Cancers & Disorders support group on Mayo Clinic Connect, a patient community.

Blood Cancers & Disorders Discussions

amyboylan1
Is there anything to help stop or slow progression of MGUS?

157 Replies Wed, Feb 04, 2026

sandramgus
Diagnosed: MGUS

150 Replies Wed, Feb 04, 2026

See more discussions
  1. Hodgkin lymphoma. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1439. Accessed Aug. 19, 2025.
  2. Hodgkin lymphoma treatment (PDQ) — Patient version. National Cancer Institute. https://www.cancer.gov/types/lymphoma/patient/adult-hodgkin-treatment-pdq. Accessed Aug. 19, 2025.
  3. Elsevier Point of Care. Clinical Overview: Hodgkin lymphoma. https://www.clinicalkey.com. Accessed Aug. 19, 2025.
  4. Cancer stat facts: Hodgkin lymphoma. National Cancer Institute. https://seer.cancer.gov/statfacts/html/hodg.html. Accessed Aug. 19, 2025.
  5. Hoffman R, et al. Hodgkin lymphoma. In: Hematology: Basic Principles and Practice. 8th ed. Elsevier; 2023. https://www.clinicalkey.com. Accessed Aug. 19, 2025.
  6. Ferri FF. Hodgkin lymphoma. In: Ferri's Clinical Advisor 2026. Elsevier; 2026. https://www.clinicalkey.com. Accessed Aug. 19, 2025.
  7. Ng AK, et al. Classic Hodgkin lymphoma: Presentation, evaluation, and diagnosis in adults. https://www.uptodate.com/contents/search. Accessed Aug. 19, 2025.
  8. LaCasce AS, et al. Pretreatment evaluation, staging, and treatment stratification of classic Hodgkin lymphoma. https://www.uptodate.com/contents/search. Accessed Aug. 19, 2025.
  9. LaCasce AS. Treatment of relapsed or refractory classic Hodgkin lymphoma. https://www.uptodate.com/contents/search. Accessed Aug. 19, 2025.
  10. Chemotherapy to treat cancer. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/chemotherapy#chemotherapy-can-cause-side-effects. Accessed Aug. 19, 2025.
  11. Radiation therapy side effects. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/radiation-therapy/side-effects. Accessed Aug. 19, 2025.
  12. Laurent C, et al. Impact of expert pathologic review of lymphoma diagnosis: Study of patients from the French Lymphopath Network. Journal of Clinical Oncology. 2017; doi:10.1200/JCO.2016.71.2083.
  13. Goyal G, et al. Association between facility volume and mortality of patients with classic Hodgkin lymphoma. Cancer. 2019; doi:10.1002/cncr.32584.
  14. Member institutions. Alliance for Clinical Trials in Oncology. https://www.allianceforclinicaltrialsinoncology.org/main/public/standard.xhtml?path=%2FPublic%2FInstitutions. Accessed Aug. 19, 2025.
  15. Membership institution lists. NRG Oncology. https://www.nrgoncology.org/About-Us/Membership/Member-Institution-Lists. Accessed Aug. 19, 2025.
  16. Stem cell transplants in cancer treatments. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant#stem-cell-transplant-side-effects. Accessed Aug. 19, 2025.
  17. Elsevier Point of Care. Clinical Overview: Febrile neutropenia in adults. https://www.clinicalkey.com. Accessed Aug. 19, 2025.
  18. Immunotherapy side effects. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/side-effects. Accessed Aug. 19, 2025.
  19. Targeted therapy to treat cancer. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies. Accessed Aug. 19, 2025.

相关

相关医疗程序

Mayo Clinic 新闻

产品与服务

霍奇金淋巴瘤（霍奇金病）